NorthWest Biotherapeutics Inc (NWBO)

[Rkmatters]

They did state they would wait until the end of the trial just not in that press release. You just decide to focus on releases where they speak about possibly ending sooner. Only they don’t remind you of their own words that they plan to do the statistical analysis at the end of the trial — which isn’t the same as minimum threshold crossing. But they wouldn’t of had to because hey, they told us in August 2014 that they would remain blinded until the very end. And yes, I also believe they were subtle when they reminded us they needed a minimum of OS threshold crossing, along with ALL the treatment data clinically checked — which would be to complete at at the end. :)